114 related articles for article (PubMed ID: 22353651)
1. Effect of additional administration of tacrolimus in patients with rheumatoid arthritis treated with biologics.
Miyata M; Asano T; Satoh S
Fukushima J Med Sci; 2011; 57(2):54-9. PubMed ID: 22353651
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of tacrolimus in comparison with methotrexate or biologics in propensity score-matched patients with rheumatoid arthritis.
Nakajima A; Inoue E; Taniguchi A; Momohara S; Yamanaka H
Mod Rheumatol; 2016 Nov; 26(6):836-843. PubMed ID: 26934454
[TBL] [Abstract][Full Text] [Related]
3. Prediction of DAS28-CRP remission in patients with rheumatoid arthritis treated with tacrolimus at 6 months by baseline variables.
Aramaki T; Kawakami A; Iwamoto N; Fujikawa K; Kawashiri SY; Tamai M; Arima K; Kamachi M; Yamasaki S; Nakamura H; Nakashima M; Mizokami A; Furuyama M; Matsuoka N; Ueki Y; Ida H; Origuchi T; Aoyagi K; Eguchi K
Mod Rheumatol; 2009; 19(6):652-6. PubMed ID: 19787419
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy and safety of add-on tacrolimus for persistent, active rheumatoid arthritis despite treatment with methotrexate and tumor necrosis factor inhibitors.
Naniwa T; Iwagaitsu S; Kajiura M
Int J Rheum Dis; 2018 Mar; 21(3):673-687. PubMed ID: 29314738
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of adjunct tacrolimus treatment in patients with rheumatoid arthritis with inadequate responses to methotrexate.
Kitahama M; Nakajima A; Inoue E; Taniguchi A; Momohara S; Yamanaka H
Mod Rheumatol; 2013 Jul; 23(4):788-93. PubMed ID: 22975732
[TBL] [Abstract][Full Text] [Related]
6. The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care.
Salaffi F; Ciapetti A; Gasparini S; Carotti M; Bombardieri S;
Clin Exp Rheumatol; 2012; 30(6):912-21. PubMed ID: 22935335
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of tacrolimus in infliximab-refractory progressive rheumatoid arthritis.
Yokota K; Akiyama Y; Asanuma Y; Miyoshi F; Sato K; Mimura T
Rheumatol Int; 2009 Feb; 29(4):459-61. PubMed ID: 18802706
[TBL] [Abstract][Full Text] [Related]
8. Can Cyclosporine-A associated to methotrexate maintain remission induced by anti-TNF agents in rheumatoid arthritis patients? (Cynar pilot study).
Migliore A; Bizzi E; Massafra U; Vacca F; Martin Martin LS; Ferlito C; Podestà E; Granata M; Laganà B
Int J Immunopathol Pharmacol; 2010; 23(3):783-90. PubMed ID: 20943048
[TBL] [Abstract][Full Text] [Related]
9. Midterm clinico-radiologic findings of an open label observation study of add-on tacrolimus with biologics or non-biologic DMARDs.
Takakubo Y; Tamaki Y; Hirayama T; Iwazaki K; Yang S; Sasaki A; Nakano H; Konttinen YT; Takagi M
Rheumatol Int; 2012 Nov; 32(11):3487-94. PubMed ID: 22065071
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study.
Furst DE; Saag K; Fleischmann MR; Sherrer Y; Block JA; Schnitzer T; Rutstein J; Baldassare A; Kaine J; Calabrese L; Dietz F; Sack M; Senter RG; Wiesenhutter C; Schiff M; Stein CM; Satoi Y; Matsumoto A; Caldwell J; Harris RE; Moreland LW; Hurd E; Yocum D; Stamler DA
Arthritis Rheum; 2002 Aug; 46(8):2020-8. PubMed ID: 12209503
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the DAS28-CRP and DAS28-ESR in patients with rheumatoid arthritis.
Sengul I; Akcay-Yalbuzdag S; Ince B; Goksel-Karatepe A; Kaya T
Int J Rheum Dis; 2015 Jul; 18(6):640-5. PubMed ID: 26013310
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus, a calcineurin inhibitor, overcomes treatment unresponsiveness mediated by P-glycoprotein on lymphocytes in refractory rheumatoid arthritis.
Suzuki K; Saito K; Tsujimura S; Nakayamada S; Yamaoka K; Sawamukai N; Iwata S; Nawata M; Nakano K; Tanaka Y
J Rheumatol; 2010 Mar; 37(3):512-20. PubMed ID: 20080907
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of additional administration of tacrolimus in patients with rheumatoid arthritis who showed an inadequate response to tocilizumab.
Kaneshiro S; Ebina K; Hirao M; Tsuboi H; Nishikawa M; Nampei A; Nagayama Y; Takahi K; Noguchi T; Owaki H; Hashimoto J; Yoshikawa H
Mod Rheumatol; 2017 Jan; 27(1):42-49. PubMed ID: 27181115
[TBL] [Abstract][Full Text] [Related]
14. Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use.
Takahashi N; Fujibayashi T; Kida D; Hirano Y; Kato T; Kato D; Saito K; Kaneko A; Yabe Y; Takagi H; Oguchi T; Miyake H; Watanabe T; Hayashi M; Kanayama Y; Funahashi K; Hanabayashi M; Hirabara S; Asai S; Takemoto T; Terabe K; Asai N; Yoshioka Y; Ishiguro N; Kojima T
Rheumatol Int; 2015 Oct; 35(10):1707-16. PubMed ID: 25991396
[TBL] [Abstract][Full Text] [Related]
15. Comparison of golimumab 100-mg monotherapy to golimumab 50 mg plus methotrexate in patients with rheumatoid arthritis: Results from a multicenter, cohort study.
Yonemoto Y; Okamura K; Takeuchi K; Ayabe K; Kaneko T; Matsushita M; Tamura Y; Iso T; Okura C; Otsuka K; Inoue H; Takagishi K
Mod Rheumatol; 2016; 26(1):24-8. PubMed ID: 26140464
[TBL] [Abstract][Full Text] [Related]
16. Prevention of joint destruction by tacrolimus in patients with early rheumatoid arthritis: a post hoc analysis of a double-blind, randomized, placebo-controlled study.
Tanaka Y; Kawai S; Takeuchi T; Yamamoto K; Miyasaka N
Mod Rheumatol; 2013 Nov; 23(6):1045-52. PubMed ID: 23271170
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of methotrexate effect on the acute-phase response in rheumatoid arthritis after 12-week treatment].
Murav'ev IuV; Gridneva GI; Karateev DE; Luchikhina EL; Omonin IuL; Aleksandrova EN; Kashnikova LN; Glukhova SI; Nasonov EL
Klin Med (Mosk); 2014; 92(3):59-63. PubMed ID: 25269199
[TBL] [Abstract][Full Text] [Related]
18. Serum level of reactive oxygen metabolites (ROM) at 12 weeks of treatment with biologic agents for rheumatoid arthritis is a novel predictor for 52-week remission.
Nakajima A; Aoki Y; Sonobe M; Takahashi H; Saito M; Nakagawa K
Clin Rheumatol; 2017 Feb; 36(2):309-315. PubMed ID: 27858176
[TBL] [Abstract][Full Text] [Related]
19. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan.
Matsui T; Kuga Y; Kaneko A; Nishino J; Eto Y; Chiba N; Yasuda M; Saisho K; Shimada K; Tohma S
Ann Rheum Dis; 2007 Sep; 66(9):1221-6. PubMed ID: 17369281
[TBL] [Abstract][Full Text] [Related]
20. Effect of Sanhuangyilong decoction plus methotrexate on tumor necrosis factor alpha and interferon gamma in serum and synovial fluid in rheumatoid arthritis patients with symptom pattern of damp heat obstruction.
Liu D; Yan J; Yun M; Yang M; Luo Y; Zhang J; Guo M; Yang M; Yuan W; Zou W; Li H; Hu Y
J Tradit Chin Med; 2016 Oct; 36(5):625-33. PubMed ID: 29933531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
